C4289946||Acute Ph-negative lymphoblastic leukemias
C0035648||Risk factors
C2348563||ALL-2009 protocol
C0035648||risk factors
C0035648||risk factors
C0079611||immunophenotype
C0023518||leukocytosis
C0022917||lactate dehydrogenase
C0022917||lactate dehydrogenase
C0243102||activity
C0544452||remission
C0008625||cytogenetic abnormalities
C0023449||acute lymphoblastic leukemia
C0023449||acute lymphoblastic leukemia
C2348563||ALL-2009 protocol
C2348563||protocol
C0043210||women
C0033011||pregnant women
C0025266||men
C4289946||Ph-negative ALL
C0279593||B-cell ALL
C0279593||pre-B ALL
C0023449||acute lymphoblastic leukemia
C0279593||pre-B ALL
C0279592||T-cell ALL
C0279592||T-ALL
C0040113||thymic
C0279592||T-ALL
C0279592||T-ALL
C0022877||laboratory
C0449381||parameters
C0023518||leukocytosis
C0279593||B-ALL
C0279592||T-ALL
C0279593||B-ALL
C0279592||T-ALL
C0022917||lactate dehydrogenase
C0243102||activity
C0150312||presence
C0040715||translocation t(4;11)
C0279593||B-ALL
C0279592||T-ALL
C0279592||T-ALL
C0194037||autologous bone marrow transplantation
C0005961||bone marrow transplantation
C0149615||Allogeneic BMT
C4049995||induction phase
C0220825||investigation
C0679867||relapse-free
C0279593||B-ALL
C0279592||T-ALL
C0035648||risk factors
C0279592||T-ALL
C0279593||B-ALL
C0729502||chemotherapeutic
C0149615||allogeneic BMTs
C0087111||treatment
C0456984||results
C0023449||acute lymphoblastic leukemia
C0010858||cytostatic
C0010858||cytostatic
C0456984||results
C0035970||Russian
C0220825||investigation
C0149615||allogeneic BMTs
C0023449||acute lymphoblastic leukemia